The 5th edition of the International HBV Cure Workshop featured the world's most prominent and distinguished speakers that discussed the most current and trending issues in the field.
Meeting category
Date(s)
7 Nov 2018
Location
Toronto,
Canada
Meeting type
Live Meeting
Organizer
International Workshop on HBV Cure 2018
Related Enduring Materials
Enduring Materials
Program
Wednesday, 7 November 2018
- 08:00
08:00 EDT
Welcome
Session 1: Modulating approved therapies to achieve HBV Cure - 08:05
Harry Janssen, MD, PhD
08:05 EDT
What is the cure rate with current therapies?
Erasmus MC, University Hospital Rotterdam, the Netherlands / Toronto Centre for Liver Disease, Canada
08:20 EDT
Stopping Nucleos(t)ide Analogues: When is it beneficial, when is it dangerous?
Session 2: New Endpoints and Biomarkers - 10:00
10:00 EDT
What are the pros and cons of HBsAg loss as the endpoint for treatment?
10:15 EDT
Can we measure (activity of) cccDNA in the blood?
10:30 EDT
Will HBsAg depletion restore HBV specific immunity?
Session 3: Update on Immune Targets for HBV Therapy - 11:35
11:35 EDT
Rationale for modulating innate immunity: TLR, RIG- and others
12:00 EDT
Activating Toll-like receptor (TLR)-8 with GS-9688 for HBV therapy
Simon Fletcher
Gilead Sciences, Foster City, USA
Session 4: Update on Virologic Targets for HBV Therapy - 15:15
Stephen Locarnini, BSc(Hons), PhD, MBBS, FRC(Path)
15:15 EDT
Rationale for different Virological Targets in HBV
Victorian Infectious Diseases Reference Laboratory
17:00 EDT
Closure of the Workshop
Overview
Welcome
We are pleased to look back on a very succesful 5th edition of the International HBV Cure Workshop, held in Toronto, ON, Canada on Wednesday 7 November 2018.
More than 100 delegates attended the workshop and the Organizing committee and organizers would like to thank the speakers, chairs and all participants for their contribution to this meeting! In particular we would like to thank our workshop sponsors. Without their financial contribution this workshop would not have been made possible.
The slides and the webcasts of the presentations given during the meeting (provided the speaker's consent was received) are soon available at http://www.infectiousdiseasesonline.com.
We look forward to seeing you again at the next International HBV Cure Workshop.
The Organizing committee
Background
More than 250 million people are chronically infected with hepatitis B (HBV) around the globe. The purpose of the program is to inform the participants about the developments in the possibilities to find a cure for HBV. The meeting will be highly interactive with input from experts out of the arena of basic, translational and clinical HBV research.
The field of HBV treatment is undergoing major changes and is on the verge of a paradigm shift. The many new treatment options that are becoming available are providing great hopes for decreasing the burden of the disease, simplifying treatment and ultimately curing and eradicating HBV infection.
In order to optimize curative treatment for HBV, outstanding speakers from around the globe will share the newest therapeutic options for viral hepatitis and experts will discuss the path forward to cure this deadly disease, leading to liver cirrhosis and liver cancer. Questions on which end points to use in therapeutic trials and how to combine different agents targeting the virus and/or immune system will be extensively discussed.
This workshop also brings together global inter-disciplinary experts to provide a framework for how academia and industry should could collaborate to achieve the goal of curing hepatitis B.
Committees
Organizing Committee
The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific program of the workshop, identify interesting topics and candidate speakers.
Support
Sliver Level
Bronze Level
Contributor
Official Media Partners
Language
Related Programs
